Trial Profile
Efficacy and safety of inhaled compared with subcutaneous human insulin [Exubera] therapy in subjects with type 2 diabetes mellitus: a six-month, outpatient, parallel comparative trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2007
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Feb 2007 New trial record.